Thrombopoietin (TPO) is a growth factor that controls platelet production. Despite the known association of chronic hypoxia and acute asphyxia with hematologic changes, TPO had not been studied in neonatal asphyxia.
INTRODUCTION
More than 800,000 neonates die worldwide as a consequence of birth asphyxia each year. An equal number of neonates suffer from epilepsy, mental retardation and cerebral palsy due to birth asphyxia. 1 Theories relate pathogenesis of brain injury to inflammation, cytokine production, complement activation, protein C and protein S deficiency among others. 2 Thrombopoietin (TPO) is a cytokine that is detected in the brain, liver and other organs. Its major role is to stimulate the production and maturation of megakaryocytes and therefore, is considered the major physiologic regulator of platelet levels. [3] [4] [5] [6] TPO is increased during periods of hypoxia while living in high altitudes, and in individuals exposed to trauma or stress. [7] [8] [9] Response of TPO to stress in general and to hypoxia in particular has stimulated our interest to examine it further in neonates and to evaluate whether TPO levels in asphyxia correlate with the clinical grade of encephalopathy.
PATIENTS AND METHODS Patients
This prospective study was conducted on 32 full term or near term neonates diagnosed with asphyxia and admitted at the neonatal intensive care unit (NICU) at Cairo University. Infants were diagnosed with asphyxia if they had demonstrated at least two of the following; Apgar score r3 at 1 minute or r6 at 5 minutes, umbilical cord arterial pH r7.2 with base deficit >10 mmol/l, and the presence of postnatal clinical complications attributed to perinatal asphyxia, such as hypotension requiring inotropic support, severe apnea and oliguria. 10 In all, 30 age-matched, apparently healthy admissions were recruited as a control group. Infants were excluded from the study if they met any of the following conditions: (1) if thrombocytopenia was attributed to causes other than asphyxia such as, sepsis, disseminated intravascular coagulopathy and maternal medications and/or diseases that may cause thrombocytopenia, (2) if they were diagnosed with life threatening congenital anomalies, anemia, and small for gestational age, or (3) if they died before 72 hours of life. This study was approved by Cairo University Children's Hospital and was conducted in accordance with the University bylaws for human research.
Methods
Full maternal and perinatal history was obtained for all subjects. Hypoxic ischemic encephalopathy (HIE) was assessed during the first 24 hours. HIE was defined as mild, moderate or severe using the Sarnat and Sarnat staging system. 11 The assessed elements include, level of consciousness, muscle tone, tendon and complex reflexes, seizures, autonomic function and electroencephalogram (EEG) description. Laboratory tests for all subjects included complete blood count and serum TPO level by ELISA technique at a postnatal age of 1, 3 and 7 days.
TPO Assay
Serum samples were collected in a serum separator tube and were allowed to clot for 30 minutes. Samples were then centrifuged for 10 minutes at 1000 Â g. Separated serum was collected and stored at rÀ201C.
A quantitative measurement of serum TPO was performed using an enzyme-linked immunosorbant assay (ELISA). The commercially available monoclonal antibody specific for TPO (R & D System Inc., Minneapolis, MN) had been precoated onto a microplate. Standards and samples were pipetted into the wells and any TPO present was bound by the immobilized antibody. After washing away any unbound substances, an enzyme-linked monoclonal antibody specific for TPO was added to the wells. Following a wash to remove any unbound antibody-enzyme reagent, a substrate solution was added to the wells and color developed in proportion to the amount of TPO bound in the initial step. Once the color development had stopped, the intensity of the color was measured.
Statistical Analysis
Comparisons between the two groups were made using two-tailed Student's t-test, and w 2 test for continuous and parametric variables. Kruskal-Wallis test was used for data with non-guasian distribution. Correlation of TPO with clinical severity and platelet count was carried out using Pearson's correlation coefficient. Logistic regression analyses were used to eliminate the effect of other confounding variables such as sex, gestational age and birth weight between groups. Data are expressed as mean±SD (total range). Regression coefficients are expressed as (RC±SEM).
RESULTS
Infants diagnosed with asphyxia were similar to those in the control group in weight, gestational age and mode of delivery. Clear male dominance in the asphyxia group was present when compared to control (81.2 vs 53.3%; p ¼ 0.007). The demographic and clinical data of the cases and controls are shown in Table 1 . A pediatrician attended 29 of the 32 deliveries. Resuscitative measures for the attended deliveries (n ¼ 29) included bag and mask ventilation (n ¼ 10), endotracheal intubation (n ¼ 19), chest compression (n ¼ 3) and inotropic and buffer medication administration (n ¼ 2). Initial blood gases of these cases showed pH of 7.05±0.14 (range ¼ 6.8 to 7.2), PCO 2 of 59.69±13.9 mmHg (range ¼ 35.1 to 100), HCO 3À of 11.17±2.15 mEq (range ¼ 6.9 to 16.4) and base deficit of À16.52±3.07 mmol/l (range ¼ À25.6 to À10.7). Encephalopathy was defined as mild in 17 (53.1%) cases, 3 ; p<0.001). The difference in platelet count disappeared at days 3 and 7. In the asphyxiated group, platelet count established negative correlation with TPO at day 1 (r ¼ 0.415; p ¼ 0.02), day 3 (r ¼ 0.64; p ¼ 0.001) and day 7 (r ¼ 0.562; p ¼ 0.007) (Figure 1 ). The mode of delivery did not influence platelet count or TPO level in asphyxiated infants.
Platelet count did not differ in those who survived and those who died, nor was there any correlation of platelet count and the grade of encephalopathy in asphyxiated infants.
Serum TPO did not differ between cases and controls on day 1 (900.2±526.4 vs 726.6±441.9 pg/ml, p ¼ 0.2, respectively). However, by day 3, TPO was significantly increased in asphyxiated infants (1291.4±627.9 vs 885.5±400.3 pg/ml, p ¼ 0.004) (Figure 2) . Such difference remained significant after controlling for other confounders in a logistic regression model (RC ¼ 476.9±146.8; p ¼ 0.002). The difference in TPO levels between asphyxiated infants who later died compared to those who survived did not reach significance (1613.1±605.9 vs 1197.1±596.8 pg/ml, p ¼ 0.09). However, TPO correlated positively with Sarnat's staging for severity of encephalopathy by day 7 (r ¼ 0.59, p ¼ 0.003) (Figure 3 ). 
DISCUSSION
Serum TPO level increased significantly in asphyxiated infants when compared to controls by day 3 of life. TPO levels measured at day 7, correlated significantly with the clinical degree of severity of asphyxia.
TPO was not previously monitored as a marker for neonatal asphyxia, yet we had enough leads to investigate such a relationship. Studies have shown platelets and TPO to be influenced by hypoxia and stress in the adult population. Living in a relatively hypoxic environment such as high altitudes produces thrombocytosis. 7 Others reported increased TPO level within 48 to 72 hours following major stresses or insults such as trauma. 9 The interaction of platelets with stress was similarly demonstrated in neonates. Asphyxiated neonates tend to have thrombocytopenia regardless of the mode of delivery 12 and nonasphyxiated neonates delivered vaginally have elevated TPO levels when compared to nonstressed cesarean deliveries. 8 Stress itself is known to cause other hematological responses such as increased nucleated red blood cells in neonatal asphyxia. 13 In our study, the majority of asphyxiated infants (81.3%) were male. The clear male predominance, though surprising, is not considered accidental. Further probing of the relation of male gender and neonatal vulnerability, showed such a relationship has been the focus of several studies. [14] [15] [16] Hypotheses regarding the male predominance include dysfunction of the placenta or increased metabolic demands in male fetuses. [17] [18] [19] Although some studies denied any relation of sex and TPO level in thrombocytopenic term and preterm newborns, this observation is not necessarily applicable to asphyxiated infants. 20 Therefore, we utilized a logistic regression model to control for any influence of gender on serum TPO.
We observed a significant negative correlation between TPO and platelet count in all samples from 1, 3 and 7 days of life. These findings were in accord with several other studies. 20, 21 Neonatal thrombocytopenia is caused by several maternal, fetal and neonatal conditions that include severe infection, pregnancy-induced hypertension, birth asphyxia and other immune mechanisms. 22 These conditions ultimately cause thrombocytopenia by increasing platelet destruction or decreasing platelet production. In general, TPO level is expected to be high if thrombocytopenia is due to megakaryocytes deficiency and low if thrombocytopenia is due to increased platelet destruction. 23 In our study, we did not detect a correlation between the mode of delivery and TPO levels. This observation disagreed with previous reports of increased TPO in neonates delivered vaginally when compared to those delivered by cesarean section. 8 Increased TPO levels have been thought to be due to stress rather than to the mode of delivery per se. Stress associated with vaginal delivery seems to be trivial relative to the severe stress caused by asphyxia.
In conclusion, TPO levels are increased in asphyxiated neonates and they correlate with the grade of encephalopathy.
